HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rachel L Cowen Selected Research

DX 52-1

2/2006Reversing hypoxic cell chemoresistance in vitro using genetic and small molecule approaches targeting hypoxia inducible factor-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rachel L Cowen Research Topics

Disease

13Neoplasms (Cancer)
03/2010 - 01/2002
9Hypoxia (Hypoxemia)
04/2016 - 06/2003
2Fibrosarcoma
04/2016 - 04/2007
2Infections
04/2007 - 11/2002
2Breast Neoplasms (Breast Cancer)
09/2003 - 06/2003
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2010
1Ectopic ACTH Syndrome
03/2010
1Carcinoma (Carcinomatosis)
04/2007
1Colonic Neoplasms (Colon Cancer)
04/2005
1Glioma (Gliomas)
11/2002

Drug/Important Bio-Agent (IBA)

5EnzymesIBA
08/2005 - 11/2002
4Oxidoreductases (Dehydrogenase)IBA
04/2016 - 06/2003
4ProdrugsIBA
05/2009 - 11/2002
4Pharmaceutical PreparationsIBA
08/2005 - 11/2002
3Oxygen (Dioxygen)IBA
05/2009 - 02/2006
3Nitric Oxide Synthase (NO Synthase)IBA
05/2009 - 06/2003
2AQ4NIBA
04/2016 - 05/2009
2Complementary DNA (cDNA)IBA
04/2016 - 02/2004
2Peptides (Polypeptides)IBA
03/2010 - 06/2003
2CytokinesIBA
05/2009 - 05/2009
2Proteins (Proteins, Gene)FDA Link
02/2006 - 05/2005
1Cytotoxins (Cytolysins)IBA
04/2016
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
04/2016
1Heme (Haem)IBA
04/2016
1CorticosteroneIBA
03/2010
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
03/2010
1Adrenocorticotropic Hormone (ACTH)FDA Link
03/2010
1Topoisomerase II InhibitorsIBA
05/2009
1Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2009
1Arginine (L-Arginine)FDA Link
05/2009
1Carboxylesterase (Hydrolase S)IBA
04/2007
1Irinotecan (Camptosar)FDA LinkGeneric
04/2007
1Hypoxia-Inducible Factor 1IBA
04/2007
1Etoposide (VP 16)FDA LinkGeneric
02/2006
1DX 52-1IBA
02/2006
1Glutathione (Reduced Glutathione)IBA
08/2005
1Antineoplastic Agents (Antineoplastics)IBA
08/2005
1AnthracyclinesIBA
08/2005
1CytochromesIBA
08/2005
1Doxycycline (Periostat)FDA LinkGeneric
04/2005
1Green Fluorescent ProteinsIBA
04/2005
1Tirapazamine (SR 4233)IBA
02/2004
1Complement System Proteins (Complement)IBA
02/2004
1ElementsIBA
02/2004
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
02/2004
1Cisplatin (Platino)FDA LinkGeneric
02/2004
1Mitomycin (Mitomycin-C)FDA LinkGeneric
09/2003
1Drug CombinationsIBA
09/2003
1NAD(P)H Dehydrogenase (Quinone) (Quinone Reductase)IBA
09/2003
1NADPH-Ferrihemoprotein Reductase (Cytochrome P450 Reductase)IBA
09/2003
1NADP (NADPH)IBA
06/2003
1Peptide Elongation Factor 1 (EF-1)IBA
06/2003
1Cytochromes c (Cytochrome c)IBA
06/2003
1Free RadicalsIBA
06/2003
1PuromycinIBA
06/2003
1Lomustine (CCNU)FDA Link
11/2002
1Thymidine KinaseIBA
11/2002
1Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA
11/2002
1quinone (benzoquinone)IBA
01/2002

Therapy/Procedure

4Therapeutics
09/2008 - 01/2004
4Drug Therapy (Chemotherapy)
08/2005 - 01/2002
3Radiotherapy
04/2016 - 02/2004